Table A3.
Patients on Study P9641 Who Experienced at Least One Grade 3 or 4 Toxicity by Type of Toxicity
| Toxicity Type | Chemotherapy* (n = 161) |
No Chemotherapy† (n = 3) |
||
|---|---|---|---|---|
| No. of Patients | Incidence (%) | No. of Patients | Incidence (%) | |
| Allergy (to drug, presumably carboplatin or etoposide) | 2 | 1.2 | 0 | 0.0 |
| Kidney | 1 | 0.6 | 0 | 0.0 |
| Liver | 15 | 9.3 | 0 | 0.0 |
| Infection | 58 | 36.0 | 1 | 33.3 |
| GI | 20 | 12.4 | 0 | 0.0 |
| Marrow | 131 | 81.4 | 2 | 66.7 |
| Weight loss | 1 | 0.6 | 0 | 0.0 |
| Other | 27 | 16.8 | 1 | 33.3 |
*
Over all courses of chemotherapy that the patient received.
†
During the observation period while the patient was on study.